Repligen Corporation (RGEN): Price and Financial Metrics

RGEN POWR Grades

• Quality is the dimension where RGEN ranks best; there it ranks ahead of 53.25% of US stocks.
• RGEN's strongest trending metric is Growth; it's been moving down over the last 177 days.
• RGEN's current lowest rank is in the Momentum metric (where it is better than 10.23% of US stocks).

RGEN Stock Summary

• With a price/earnings ratio of 47.88, REPLIGEN CORP P/E ratio is greater than that of about 88.12% of stocks in our set with positive earnings.
• Price to trailing twelve month operating cash flow for RGEN is currently 51.74, higher than 92.15% of US stocks with positive operating cash flow.
• RGEN's price/sales ratio is 11.11; that's higher than the P/S ratio of 90.66% of US stocks.
• If you're looking for stocks that are quantitatively similar to REPLIGEN CORP, a group of peers worth examining would be TECH, STAA, OSIS, APPS, and PLAB.
• RGEN's SEC filings can be seen here. And to visit REPLIGEN CORP's official web site, go to www.repligen.com.

RGEN Valuation Summary

• RGEN's price/sales ratio is 11.1; this is 484.21% higher than that of the median Healthcare stock.
• RGEN's price/sales ratio has moved down 12 over the prior 243 months.

Below are key valuation metrics over time for RGEN.

RGEN Growth Metrics

The 5 year net income to common stockholders growth rate now stands at 76.56%.
• Its 4 year net income to common stockholders growth rate is now at 76.56%.
• The 3 year cash and equivalents growth rate now stands at 198.08%.

RGEN's revenue has moved up $617,834,000 over the prior 52 months.

The table below shows RGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	801.536	172.083	185.959
2022-09-30	801.295	159.821	166.34
2022-06-30	778.77	140.937	159.433
2022-03-31	734.097	132.867	145.805
2021-12-31	670.534	119.016	128.291
2021-09-30	592.661	84.267	118.879

RGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RGEN has a Quality Grade of C, ranking ahead of 39.46% of graded US stocks.
• RGEN's asset turnover comes in at 0.293 -- ranking 157th of 682 Pharmaceutical Products stocks.
• ORMP, MESO, and AWH are the stocks whose asset turnover ratios are most correlated with RGEN.

The table below shows RGEN's key quality metrics over time.